(Q35055829)

6 August 2017

title

Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysis (English)

1 reference

6 August 2017

8

Michael Linnebank

1 reference

6 August 2017

Katrin Patrij

1

1 reference

6 August 2017

Marcel Reiser

2

1 reference

6 August 2017

Luise Wätzel

3

1 reference

6 August 2017

Hendrik Pels

4

1 reference

6 August 2017

Annika Kowoll

5

1 reference

6 August 2017

Ulrich Herrlinger

6

1 reference

6 August 2017

Andreas Engert

7

1 reference

6 August 2017

Gabriele Schackert

9

1 reference

6 August 2017

Marlies Vogt-Schaden

10

1 reference

6 August 2017

Gerlinde Egerer

11

1 reference

6 August 2017

Monika Lamprecht

12

1 reference

6 August 2017

Tracy T Batchelor

13

1 reference

6 August 2017

Uwe Schlegel

14

1 reference

6 August 2017

Ingo G H Schmidt-Wolf

15

1 reference

6 August 2017

International Primary CNS Lymphoma Collaborative Group (IPCG)

16

1 reference

6 August 2017

publication date

2 May 2011

1 reference

German medical science : GMS e-journal

6 August 2017

published in

1 reference

6 August 2017

volume

9

1 reference

6 August 2017

page(s)

Doc11

1 reference

Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118693

Secondary lymphomas of the central nervous system: risk, prophylaxis and treatment.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118693

Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118693

Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118693

Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118693

Central nervous system relapse of lymphoid malignancies in adults: the role of high-dose chemotherapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118693

Central nervous system relapse in non-Hodgkin lymphoma. A single-center study of 532 patients.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118693

Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118693

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118693

Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118693

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118693

Response criteria for phase II studies of supratentorial malignant glioma

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3118693

Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lympho

25 October 2018

1 reference

12 December 2020

Risk Factors for Central Nervous System Involvement in Non-Hodgkins-Lymphoma a multivariate analysis

1 reference

12 December 2020

The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma

1 reference

12 December 2020

Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report

1 reference

12 December 2020

Identifiers

DOI

10.3205/000134

1 reference

6 August 2017

1 reference

6 August 2017

1 reference